May 7, 2020
On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs immediately. The recall is the latest action the FDA is taking in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA). Ranitidine products won’t be available for new or existing prescriptions or OTC use in the United States.
Patients are advised to stop taking OTC ranitidine products and find an appropriate alternative. Patients with a prescription medication should continue to take it as directed and contact their provider for alternative treatment options.
For more information about the recall and on-going FDA investigation into ranitidine products read the FDA announcement. For questions, email provider.relationswest@premera.com.